US Broker Ratings

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Exploring an 18.64% Potential Upside in the Rare Disease Biotech Space

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands as a noteworthy contender in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $6.59 billion, this Boston-based company focuses..

Charles River Laboratories (CRL) Stock Analysis: Navigating Market Volatility with a 19.64% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL) stands at the forefront of the Healthcare sector, specializing in the Diagnostics & Research industry. With a market capitalization of $7.31 billion, Charles..

Cytokinetics, Incorporated (CYTK): Biotech Stock with 48% Upside Potential and Robust Revenue Growth

Cytokinetics, Incorporated (NASDAQ: CYTK) is making waves in the biotechnology sector with a market capitalization of $6.03 billion and a formidable presence in muscle biology drug development. This late-stage biopharmaceutical..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring an 82.77% Potential Upside in the Biotech Sector

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company, stands at a pivotal moment in its journey, offering an intriguing opportunity for investors in the healthcare sector. With a market..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Strong Revenue Growth and Promising Pipeline Signal Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a compelling figure in the biotechnology sector, captivating investors with its impressive revenue growth and innovative pipeline. Headquartered in Morrisville, North Carolina, TG..

ADMA Biologics Inc (ADMA) Stock Analysis: A Promising 86.16% Upside in the Biotech Sector

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology industry, is quietly navigating the healthcare sector with a focused mission to develop, manufacture, and market plasma-derived biologics targeting..

BrightSpring Health Services, I (BTSG) Stock Analysis: A Strong Buy with 7.40% Upside Potential

BrightSpring Health Services, Inc. (BTSG), a pivotal player in the healthcare sector, is attracting attention from investors due to its robust growth metrics and positive analyst sentiment. Operating within the..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Unlocking a 71% Upside Potential with Innovative Diagnostics

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands out in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With a market capitalization of $3.44 billion, Lantheus plays..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 50% Upside Potential with Strong Buy Ratings

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, specifically in the medical devices industry, is capturing investor interest with its substantial potential upside. Headquartered in Billerica, Massachusetts,..

RadNet, Inc. (RDNT) Stock Analysis: Growth Potential in Diagnostic Imaging with a 4.45% Upside

RadNet, Inc. (NASDAQ: RDNT), a key player within the healthcare sector, specializes in providing outpatient diagnostic imaging services. The company operates through its Imaging Centers and Digital Health segments, offering..

Telix Pharmaceuticals Limited (TLX) Investor Outlook: A Biotech Gem with Over 110% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX), a burgeoning biotech firm headquartered in North Melbourne, Australia, is making waves in the healthcare sector. With its focus on the development and commercialization of..

Stevanato Group S.p.A. (STVN) Stock Analysis: A Healthcare Innovator with 11.57% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN), a key player in the healthcare sector, is making waves in the medical instruments and supplies industry with its innovative solutions and robust market presence...

Incyte Corporation (INCY) Stock Analysis: Navigating the Biotech Sector with a Promising Forward P/E of 11.54

Incyte Corporation (INCY), a key player in the biotechnology industry, has captured the attention of investors with its innovative therapeutics and robust performance metrics. Headquartered in Wilmington, Delaware, this biopharmaceutical..

Integer Holdings Corporation (ITGR): Investor Outlook with a Promising 38.79% Upside Potential

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector specializing in medical devices, is capturing investor attention with its robust growth potential and strategic positioning in the..

Tempus AI, Inc. (TEM) Stock Analysis: Impressive Revenue Growth Amid Challenging Valuation Metrics

Tempus AI, Inc. (NASDAQ: TEM) stands as a compelling player in the healthcare technology sector, operating at the intersection of advanced diagnostics and data analytics. Founded in 2015 and headquartered..

The Ensign Group, Inc. (ENSG) Stock Analysis: Healthcare Leader with 18.5% Revenue Growth and Attractive Analyst Ratings

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a formidable player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $9.95 billion, it..

GE HealthCare Technologies Inc. (GEHC) Investor Outlook: Unlocking a 21% Potential Upside

GE HealthCare Technologies Inc. (NYSE: GEHC) is making waves in the healthcare sector with its robust portfolio and strategic focus on advanced medical technologies. With a market capitalization of $33.08..

Humana Inc. (HUM) Stock Analysis: Is the 17% Potential Upside Worth Your Investment?

Humana Inc. (NYSE: HUM) stands as a significant player in the healthcare sector, specializing in healthcare plans. With its headquarters in Louisville, Kentucky, Humana has established itself as a formidable..

Prestige Consumer Healthcare (PBH) Stock Analysis: 31.49% Potential Upside Sparks Investor Interest

Prestige Consumer Healthcare Inc. (NYSE: PBH) is a notable player in the healthcare sector, specializing in over-the-counter (OTC) health and personal care products. With a market capitalization of $3.1 billion,..

HealthEquity, Inc. (HQY) Stock Analysis: Strong Buy Ratings and 26.76% Upside Potential

HealthEquity, Inc. (NASDAQ: HQY) operates at the intersection of healthcare and technology, offering a suite of services designed to streamline financial management for health-related expenses. With a market capitalization of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds